investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Human Artificial Chromosomes for Cancer Research and Functional Genomics
Vladimir Larionov
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
William Earnshaw
University of Edinburgh
Edinburgh, United Kingdom
Mitsuo Oshimura
Tottori University
Tottori-shi, Japan
Hiroshi Masumoto
Kazusa DNA Research Institute
Kisarazu, Japan
Vladimir Larionov
National Cancer Institute (NIH)
Rockville, United States
Related projects
Birge Raymond B
Non-canonical Signal Pathway for Crk in Breast Cancer
All cancers but non-melanoma skin cancer
Peter J. Murray
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
All cancers but non-melanoma skin cancer
Mikhail Kashlev
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
All cancers but non-melanoma skin cancer
Alfred Singer
MHC-independent T cells
All cancers but non-melanoma skin cancer
Alexander Gimelbrant
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
All cancers but non-melanoma skin cancer
Stephen Hughes
Integrase
All cancers but non-melanoma skin cancer
James R. Heath
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)
All cancers but non-melanoma skin cancer
Elena Vigorito
MiRNA-155 regulates B cell function through its target PU.1
All cancers but non-melanoma skin cancer
Richard I. Gregory
Screening for drugs that restore let-7 microRNA expression in cancer
All cancers but non-melanoma skin cancer